AWM
WST icon

Apollon Wealth Management’s West Pharmaceutical WST Stock Holding History

Apollon Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
8,456
+7,089
+519% +$2.17M 0.04% 402
2026
Q1 		$343K Buy
1,367
+396
+41% +$98.5K 0.01% 1044
2025
Q4 		$267K Buy
971
+96
+11% +$26.3K ﹤0.01% 1109
2025
Q3 		$230K Sell
875
-160
-15% -$38.9K ﹤0.01% 1167
2025
Q2 		$226K Sell
1,035
-286
-22% -$61.1K ﹤0.01% 1126
2025
Q1 		$296K Buy
1,321
+126
+11% +$34.7K 0.01% 959
2024
Q4 		$391K Sell
1,195
-67
-5% -$21.1K 0.01% 845
2024
Q3 		$379K Buy
1,262
+1
+0.1% +$306 0.01% 826
2024
Q2 		$415K Sell
1,261
-126
-9% -$44.5K 0.01% 751
2024
Q1 		$549K Sell
1,387
-163
-11% -$60.3K 0.02% 662
2023
Q4 		$546K Sell
1,550
-74
-5% -$26.2K 0.02% 625
2023
Q3 		$609K Buy
1,624
+296
+22% +$114K 0.03% 496
2023
Q2 		$508K Sell
1,328
-1,678
-56% -$599K 0.02% 585
2023
Q1 		$1.04M Sell
3,006
-323
-10% -$94.4K 0.06% 315
2022
Q4 		$784K Buy
3,329
+1,001
+43% +$237K 0.06% 370
2022
Q3 		$573K Buy
2,328
+257
+12% +$78.3K 0.05% 409
2022
Q2 		$626K Buy
2,071
+448
+28% +$146K 0.05% 375
2022
Q1 		$667K Buy
1,623
+175
+12% +$68.5K 0.05% 382
2021
Q4 		$679K Buy
1,448
+50
+4% +$21.5K 0.05% 393
2021
Q3 		$594K Sell
1,398
-361
-21% -$152K 0.08% 236
2021
Q2 		$632K Buy
+1,759
New +$581K 0.11% 189

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Apollon Wealth Management's WST Position: Q2 2026 in Review

Apollon Wealth Management increased its West Pharmaceutical (WST) stake by 519% in Q2 2026, buying an estimated $2.17M and bringing the position to 8,456 shares worth $3.04M. The position accounts for 0.04% of the portfolio, ranked #402.

Apollon Wealth Management first reported a position in WST in Q2 2021 and has held it in 21 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Apollon Wealth Management held 8,456 shares of West Pharmaceutical worth $3.04M as of Q2 2026.
  • Apollon Wealth Management bought 7,089 West Pharmaceutical shares in Q2 2026, an estimated $2.17M.
  • West Pharmaceutical made up 0.04% of Apollon Wealth Management's portfolio in Q2 2026, its #402 holding.
  • Apollon Wealth Management first reported a position in West Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.